(Q44576115)

4 December 2017

title

Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy (English)

1 reference

4 December 2017

1 reference

3

1 reference

4 December 2017

Dianne Pulte

1

1 reference

4 December 2017

Adam Gondos

series ordinal

2

1 reference

4 December 2017

publication date

1 February 2009

1 reference

4 December 2017

1 reference

4 December 2017

volume

50

1 reference

4 December 2017

issue

2

1 reference

4 December 2017

page(s)

179-186

1 reference

Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

Survival benefit from high-dose therapy with autologous blood progenitor-cell transplantation in poor-prognosis non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

Up-to-date and precise estimates of cancer patient survival: model-based period analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

The relative survival rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

Non-Hodgkin lymphoma secondary to cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

Up-to-Date Long-Term Survival Curves of Patients With Cancer by Period Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802645061

10.1080/10428190802645061

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference